BOS Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Sell
509
-60
-11% -$28.8K 0.06% 170
2026
Q1
$280K Buy
569
+40
+8% +$21.7K 0.07% 163
2025
Q4
$307K Sell
529
-18
-3% -$10.2K 0.08% 149
2025
Q3
$265K Hold
547
0.07% 156
2025
Q2
$222K Buy
+547
New +$229K 0.07% 161
2024
Q4
Sell
-330
Closed -$204K 174
2024
Q3
$204K Buy
+330
New +$195K 0.08% 161
2023
Q1
Sell
-397
Closed -$219K 128
2022
Q4
$219K Buy
+397
New +$210K 0.2% 112

Other funds holding TMO

BOS Asset Management's TMO Position: Q2 2026 in Review

BOS Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $28.8K and leaving 509 shares worth $255K. The position accounts for 0.06% of the portfolio, ranked #170.

BOS Asset Management first reported a position in TMO in Q4 2022 and has held it in 7 quarters since. The position peaked at $307K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • BOS Asset Management held 509 shares of Thermo Fisher Scientific worth $255K as of Q2 2026.
  • BOS Asset Management sold 60 Thermo Fisher Scientific shares in Q2 2026, an estimated $28.8K.
  • Thermo Fisher Scientific made up 0.06% of BOS Asset Management's portfolio in Q2 2026, its #170 holding.
  • BOS Asset Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 7 quarters since.
  • BOS Asset Management's Thermo Fisher Scientific position peaked at $307K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BOS Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.